Global Health Research Center of Central Asia, Columbia University School of Social Work, Kazakhstan.
Drug Alcohol Depend. 2013 Nov;132 Suppl 1(0 1):S61-4. doi: 10.1016/j.drugalcdep.2013.07.007. Epub 2013 Jul 31.
As a population profoundly affected by the HIV epidemic and in critical need of linkages to HIV treatment and care, PWID in Central Asia remain largely underserved. This paper provides an overview of the current state of HIV testing and counseling in Central Asia for PWID, identifies main barriers leading to gaps in service delivery, and discusses implications for improving strategies that promote HIV testing for PWID.
We reviewed a number of sources for this paper including unpublished government reports, published papers, and Ministries of Health of Kazakhstan, Kyrgyzstan, Tajikistan, and Uzbekistan country progress reports to the UN General Assembly Special Session on HIV/AIDS (UNGASS) for 2012.
Between 29 and 65% of PLWH in some Central Asian countries have been tested for HIV in the last 12 months. The rates have been increasing in the recent years but still are relatively low. Stigma, discrimination, human rights violations, and repressive legislation are barriers to HTC for people who inject drugs (PWID).
The use of innovative evidence-based HTC models, such as community mobile-vans, self-testing at home, and rapid HIV testing among PWID in Central Asia are discussed and recommendations given regarding amendments in legislation and scaling up of existing community-based pilot projects to support HIV testing among PWID in CA.
作为受艾滋病流行影响深远且迫切需要与艾滋病治疗和护理相衔接的人群,中亚地区的注射吸毒者在很大程度上仍得不到充分服务。本文概述了中亚地区针对注射吸毒者的艾滋病毒检测和咨询的现状,确定了导致服务提供差距的主要障碍,并讨论了改善促进注射吸毒者艾滋病毒检测的策略的影响。
我们查阅了一些资料来完成本文,包括未发表的政府报告、已发表的论文,以及哈萨克斯坦、吉尔吉斯斯坦、塔吉克斯坦和乌兹别克斯坦卫生部向联合国大会艾滋病毒/艾滋病问题特别会议(UNGASS)提交的 2012 年国家进展报告。
在一些中亚国家,29%至 65%的艾滋病毒阳性者在过去 12 个月中接受了艾滋病毒检测。近年来,这一比例有所上升,但仍相对较低。污名化、歧视、侵犯人权和镇压性立法是妨碍注射吸毒者进行艾滋病毒检测的障碍。
讨论了在中亚地区使用创新的基于证据的艾滋病毒检测模型,如社区流动车、在家自我检测以及针对注射吸毒者的快速艾滋病毒检测,并就立法修正案和扩大现有的基于社区的试点项目以支持中亚地区注射吸毒者的艾滋病毒检测提出了建议。